NMRA welcomes your comments and feedback on the proposed Guideline for Post Marketing Surveillance of Medicine.This will start from 18th of September 2019 & end 15th of October 2019.
Please provide your name, the organization you represent, mailing address and contact number to follow up with you to clarify any issue if necessary.
Please email your feedback to This email address is being protected from spambots. You need JavaScript enabled to view it. by 15th of October 2019
Guideline for Post Marketing Surveillance of Medicine
